![](/img/cover-not-exists.png)
P-279 * Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) - 5-year experience from the Institute of Oncology and Radiology of Serbia
Spasic, J., Stanic, N., Ristic, M., Djordjevic, F., Nikolic, N., Nikolic, V., Pupovac, S., Radasavljevic, D.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.276
Date:
June, 2015
File:
PDF, 31 KB
english, 2015